SCHEMBL578087

SCHEMBL578087

Clc1[c]nc2ccccc2c1-c1nc(C2CC2)cs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
PRKAA2 P54646 1/20 0.32
TP53 P04637 1/20 0.31
NFKB1 P19838 1/20 0.31
FPR1 P21462 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TMIGD3 P0DMS9 1/20 0.30
ADORA2A P29274 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1232940 0.95 TDP1 (0.33) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL578088 0.82 ALDH1A1 (0.36) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL1232941 0.78 MAOA (0.33) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL578381 0.76
SCHEMBL578322 0.76 KDM4E (0.33) ALDH1A1
SCHEMBL577801 0.68 GABRA1 (0.39) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL19399210 0.67 KDM4E (0.51) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL577802 0.67 ALDH1A1 (0.36) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL577990 0.64 GABRA1 (0.36) ALDH1A1GABRA1GABRG2GABRB3GABRA3
SCHEMBL6223571 0.64 ALDH1A1 (0.46) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP claimed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO claimed